Skip to main content
Steve Pollard, MD, Allergy & Immunology, Louisville, KY

StevePollardMD

Allergy & Immunology Louisville, KY

Family Allergy & Asthma Co-founding Partner: Research Director

Dr. Pollard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pollard's full profile

Already have an account?

  • Office

    9800 Shelbyville Rd
    Ste 220
    Louisville, KY 40223
    Phone+1 502-429-8585
    Fax+1 502-429-6157

Education & Training

  • University of Louisville School of Medicine
    University of Louisville School of MedicineFellowship, Allergy and Immunology, 1977 - 1979
  • University of Louisville School of Medicine
    University of Louisville School of MedicineResidency, Pediatrics, 1975 - 1977
  • University of Louisville School of Medicine
    University of Louisville School of MedicineClass of 1975
  • University of Louisville
    University of LouisvilleB.A., Chemistry, 1971
  • Kentucky Southern College
    Kentucky Southern CollegeNo Degree, 1962 - 1963

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 1976 - 2025
  • KY State Medical License
    KY State Medical License 1976 - 2025
  • American Board of Allergy and Immunology Allergy & Immunology
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • One of America's Top Physicians Consumer Research Council, 2005-2006, 2008-2010
  • Elected by Peers as One of Louisville's Best Doctors Louisville Magazine, 2001, 2005
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Long-term Safety of nebulized formoterol: Results of a twelve-momth open-label clinical trial in COPD  
    Donohue F, Hanania C, Fogarty S, Campbell C, Rinehart M, Denize-Mize, ( PollardSJ-Study Group), Therapeutic Advances in Respiratory Disease, 1/1/2008
  • Evaluation of the Safety and Efficacy of Levalbuterol in 2-5 Year Old Patients with Asthma  
    Skoner D, Greos L, Kim K, Roach J, Parsey M, Baumgartner R. for the Xopenex Pediatric Study Group (Pollard SJ-Study Group), Pediatric Pulmonology, 6/1/2005
  • Efficacy and Tolerability of Montelukast Alone or in Combination with Loratadine in Seasonal Allergic Rrhinitis: a Multicenter, Ramdomized, Double-blind, Placebo-contr...  
    Nayak A, Philip G, Lu S, Malice MP, Reiss, T Montelukast Fall Rhinitis Investigator Group (Pollard SJ-Study Group), Annals of Allergy, Asthma, & Immunology, 6/1/2002
  • Join now to see all

Abstracts/Posters

  • Safety and Efficacy Experience with Rilonacept (IL-1 Trap) in Adolescents with Cryopyrin-Associated Periodic Syndromes (CAPS)
    Throne ML, Pollard SJ, Goldstein S, Hoffman HM, Grimes IM, Stein DR, Weinstein SP, Mellis SJ, American College of Rheumatology Annual Scientific Meeting, 1/1/2008
  • Effect of Omalizumab on Pulmonary Function and Symptom Scores in Adolescents with Moderate-Servere Persistent IgE-Mediated Asthma.
    Pollard S J, Maykut B J, Massanari M, Kiawifard F, Zeldin R K, Geba G P, Annals of Allergy, Asthma and Immunology, 1/1/2007
  • Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma.
    Pollard S J et al, Journal of Allergy and Clinical Immunology, 1/1/2007
  • Join now to see all

Lectures

  • "Understanding Asthma vs COPD" 
    Brandeburg, KY - 11/1/2009
  • "Assessing and Managing Asthma Control" 
    Terra Haute, IN - 8/1/2009
  • "Assesing and Managing Asthma Control" 
    Abingdon, VA - 9/1/2008
  • Join now to see all

Other

  • Recognition and Management of Asthmatic Children. 
    Stephen J. Pollard, MD, Louisville Medicine
    4/1/1981
  • Comparison of Ipratropium Bromide and Albuterol Sulfate Chlorofluorocarbon metered-dose inhaler and Albuterol Hydrofluoroalkane metered-dose inhaler in a crossover tri... 
    E. R. Bleecker, W. Busse, J. Donohue, S. Garfinkel, T. Lystig, R. C. Manuel, R. Schlenker-Herceg, R. Wise on behalf of the 1012.57 Investigators
    Wake Forest University Center of Genomics and Personalized Medicine, Winston Salem